No, lercanidipine should not be dosed at 20 mg twice daily
Lercanidipine is designed and approved for once-daily dosing only, and there is no evidence supporting or recommending twice-daily administration. The standard dosing is 10 mg once daily, with uptitration to a maximum of 20 mg once daily if needed 1.
Rationale for Once-Daily Dosing
Pharmacokinetic Properties
Lercanidipine is a highly lipophilic third-generation dihydropyridine calcium channel blocker with unique membrane-controlled kinetics that provide:
- Prolonged duration of action due to high lipid solubility and persistence in vascular smooth muscle cell membranes 2, 3, 4
- Gradual onset of vasodilation that maintains 24-hour blood pressure control with single daily dosing 3, 4
- A half-life that supports once-daily administration 2
Guideline-Based Recommendations
Current hypertension guidelines consistently emphasize:
- Once-daily dosing to improve adherence 1, 5, 6
- Simplification of regimens with single-pill combinations when possible 1
- The 2020 ISH guidelines specifically state: "Simplify regimen with once daily dosing and single pill combinations" 1
Appropriate Dosing Strategy
Standard Approach
- Start with 10 mg once daily 7, 2, 3
- Uptitrate to 20 mg once daily if blood pressure targets are not achieved after 4 weeks 7, 2
- Maximum dose: 20 mg once daily - this is the ceiling dose
If Blood Pressure Remains Uncontrolled
Rather than splitting the dose twice daily, the evidence-based approach is:
- Add a second antihypertensive agent from a different class (ACE inhibitor, ARB, or thiazide diuretic) 1, 5
- Consider combination therapy, preferably as a single-pill combination 5, 8
- The lercanidipine-enalapril combination has demonstrated superior efficacy compared to monotherapy 8
Clinical Evidence
Studies consistently demonstrate that lercanidipine 10-20 mg once daily:
- Provides effective 24-hour blood pressure control 2, 3, 4
- Achieves blood pressure normalization in 64-96% of patients with mild-to-moderate hypertension 7, 2
- Is effective across diverse populations including elderly, diabetics, and high cardiovascular risk patients 7, 9, 4
Important Caveats
There is no published evidence, FDA approval, or guideline recommendation for twice-daily lercanidipine dosing. Attempting to dose 20 mg twice daily (40 mg total daily) would:
- Exceed the maximum approved daily dose
- Potentially increase adverse effects (particularly peripheral edema, headache, flushing) without proven additional benefit
- Contradict the drug's pharmacokinetic design
- Reduce patient adherence by complicating the regimen
If lercanidipine 20 mg once daily is insufficient, add combination therapy rather than increasing frequency or exceeding the maximum dose.